• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: QUEST MEDICAL, INC. Q2 T-EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

QUEST MEDICAL, INC. Q2 T-EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 95702
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
The alleged incident occurred outside the us.This medwatch is being submitted because quest medical distributes a similar device in the us.The complaint sample will be evaluated and a follow-up medwatch will be submitted if additional information becomes available.
 
Event Description
A report was received regarding an alleged issue encountered during use of the iv administration extension set.The report states that the iv tubing pulled apart which resulted in a patient not receiving infusions and bleeding from central line insertion site.Additional information received indicates that the alleged malfunction did not result in patient complications.
 
Manufacturer Narrative
The complaint sample was inspected and the tubing was confirmed to have detached.Visual inspection showed evidence of solvent in the form of ring on the tubing, confirming the presence of solvent bonding.Pull force testing could not be conducted on the complaint sample because of the detached tubing.Inventory on the lot associated with this complaint was depleted at the time of the investigation.5 samples of the product from another lot manufactured with the same processes and conditions as the complaint sample were pull tested to determine tubing bond strength.The samples tested met the minimum bond strength specification of 8 ibs.The average bond strength of the tested samples was 14.21 ibs.A 24 months complaint history review was conducted on the part number associated with the reported complaint and no similar complaint was found.A review of the device history records for the reported complaint lot was also conducted and no anomalies were found.The root cause of the reported complaint condition is not manufacturing related and is unknown.Quest will continue to monitor complaint trends for the reported complaint condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Q2 T-EXTENSION SET
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
QUEST MEDICAL, INC.
one allentown parkway
allen TX 75002
Manufacturer (Section G)
QUEST MEDICAL, INC
one allentown parkway
allen TX 75002
Manufacturer Contact
tosan onosode
one allentown parkway
allen, TX 75002
9723326338
MDR Report Key8405790
MDR Text Key138570246
Report Number1649914-2019-00010
Device Sequence Number1
Product Code FPK
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K162304
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 04/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number95702
Device Catalogue Number95702
Device Lot Number0567388C03
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/05/2019
Date Manufacturer Received02/07/2019
Was Device Evaluated by Manufacturer? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-